Biomea Fusion BMEA
NASDAQ BMEA
$1.37 +0.01 (+0.74%)
At close: Aug 21, 2026 · 4:00 PM EDT

Biomea Fusion (BMEA) Assets Average (2021 - 2026)

Biomea Fusion (BMEA) posted Assets Average of $52.5 million for Q1 2026, down 7.74% sequentially from $56.9 million in Q4 2025, and down 22.25% YoY from $67.5 million in Q1 2025.

Biomea Fusion (BMEA) Assets Average (2021 - 2026) Analysis & Trends

Biomea Fusion has reported Assets Average for 6 years, with the latest figure at $52.5 million in Q1 2026.

  • Quarterly Assets Average fell 22.25% year-over-year to $52.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $52.5 million (down 22.25% YoY) and the FY2025 annual result came in at $69.3 million, down 50.51% from the prior year.
  • Assets Average slipped to $52.5 million in Q1 2026 per BMEA's latest filing, from $56.9 million in the prior quarter.
  • Over five years, Assets Average peaked at $236.9 million in Q3 2023 and troughed at $52.5 million in Q1 2026.
  • A 5-year average of $132.4 million and a median of $137.2 million in 2022 frame the typical range for Assets Average.
  • The sharpest annual moves came in 2022 and 2025: Assets Average soared 194.58% in 2022, then plunged 63.36% in 2025.
  • Over 5 years, Assets Average stood at $137.2 million in 2022, then surged by 54.91% to $212.5 million in 2023, then tumbled by 55.21% to $95.2 million in 2024, then slumped by 40.24% to $56.9 million in 2025, then fell by 7.74% to $52.5 million in 2026.
  • According to Business Quant data, Assets Average over the past three periods registered $52.5 million, $56.9 million, and $64.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets Avg. (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 26.95 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 41.30 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 11.22 Bn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 8.86 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 5.34 Bn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 25.27 Bn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 2.09 Bn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 19.82 Bn
10 Biomea Fusion 97.69 Mn 97.69 Mn - 41.63 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 41.63 Mn
Mar 31, 2026 52.48 Mn
Dec 31, 2025 56.88 Mn
Sep 30, 2025 64.18 Mn
Jun 30, 2025 64.11 Mn
Mar 31, 2025 67.50 Mn
Dec 31, 2024 95.18 Mn
Sep 30, 2024 123.29 Mn
Jun 30, 2024 152.33 Mn
Mar 31, 2024 184.21 Mn
Dec 31, 2023 212.51 Mn
Sep 30, 2023 236.88 Mn
Jun 30, 2023 180.66 Mn
Mar 31, 2023 120.97 Mn
Dec 31, 2022 137.18 Mn
Sep 30, 2022 153.39 Mn
Jun 30, 2022 168.30 Mn
Mar 31, 2022 180.28 Mn
Dec 31, 2021 192.55 Mn
Sep 30, 2021 204.47 Mn